Reappraisal of the drifting scenario of leprosy multi-drug therapy: new approach proposed for the new millennium

被引:12
作者
Bhattacharya, SN
Sehgal, VN
机构
[1] Sehgal Nursing Home, Dermatovenereol Skin Ctr VD, Delhi 110033, India
[2] Associated GTB Hosp Shahdara, Delhi 110095, India
[3] Univ Coll Med Sci, Dept Dermatol STD & Leprosy, Delhi 110095, India
关键词
D O I
10.1046/j.1365-4362.2002.01506.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:321 / 326
页数:6
相关论文
共 39 条
[1]  
*AN WHO ACT PROGR, 1995, GUID EL LEPR PUBL HL, P1
[2]  
*AN WHO EXP COMM L, 1998, TECH REP SER WHO, V874
[3]  
*AN WHO EXP COMM L, 1988, TECH REP SER WHO, V768
[4]  
*AN WHO STUD GROUP, 1982, CHEM LEPR CONTR PROG
[5]  
*AN WHO STUD GROUP, 1994, TECHN REP SER WHO, V847
[6]   Experimental evaluation of possible new short-term drug regimens for treatment of multibacillary leprosy [J].
Banerjee, DK ;
McDermottLancaster, RD ;
McKenzie, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) :326-330
[7]  
BECXBLEUMINK M, 1992, INT J LEPROSY, V60, P421
[8]  
BECXBLEUMINK M, 1992, INT J LEPROSY, V60, P436
[9]   Leprosy in India [J].
Bhattacharya, SN ;
Sehgal, VN .
CLINICS IN DERMATOLOGY, 1999, 17 (02) :159-170
[10]   Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae [J].
Cambau, E ;
Perani, E ;
Guillemin, I ;
Jamet, P ;
Ji, BH .
LANCET, 1997, 349 (9045) :103-104